Subtopic Deep Dive
Epidemiology of Type 1 Diabetes Incidence Trends
Research Guide
What is Epidemiology of Type 1 Diabetes Incidence Trends?
Epidemiology of Type 1 Diabetes Incidence Trends studies the global patterns, rising rates in youth, and projections of pediatric-onset type 1 diabetes using registries and cohort analyses.
Registries like DIAMOND and EURODIAB track incidence per 100,000 children under 15, showing increases from 1990-1999 (DIAMOND Project Group, 2006; 1072 citations) and 1989-2003 in Europe (Patterson et al., 2009; 1850 citations). U.S. data from 2002-2012 confirm rising type 1 diabetes in youths, especially minorities (Mayer-Davis et al., 2017; 1450 citations). Over 100 centers worldwide contribute to these trends.
Why It Matters
Rising incidence strains public health systems, with projections estimating new cases through 2020 (Patterson et al., 2009). U.S. surveillance reveals 2002-2012 increases, informing resource allocation for minority youth (Mayer-Davis et al., 2017). Global monitoring from 1990-1999 highlights highest rates in developed nations, guiding prevention amid undiagnosed cases (DIAMOND Project Group, 2006; Deshpande et al., 2008).
Key Research Challenges
Heterogeneous Global Registries
Standardizing data across 57 countries and 112 centers remains difficult, as seen in 1990-1999 analyses (DIAMOND Project Group, 2006). Variations in diagnostic criteria and reporting delay trend accuracy (Patterson et al., 2009). Over 100 populations require harmonized methods.
Distinguishing Incidence Drivers
Separating birth cohort effects from period effects challenges causal inference in youth trends (Mayer-Davis et al., 2017). Migration and accelerator hypotheses lack unified testing (Karvonen et al., 2000). Minority group surges complicate attribution.
Projecting Future Burdens
Modeling post-2020 cases under urbanization ignores climate variables, extending 2005-20 forecasts (Patterson et al., 2009). U.S. 2002-2012 data show unpredictable minority rises (Mayer-Davis et al., 2017). Long-term registries need advanced simulations.
Essential Papers
Chronic inflammation in the etiology of disease across the life span
David Furman, Judith Campisi, Eric Verdin et al. · 2019 · Nature Medicine · 4.3K citations
C-reactive protein: a critical update
Mark B. Pepys, Gideon M. Hirschfield · 2003 · Journal of Clinical Investigation · 3.3K citations
Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study
Christopher Patterson, Gisela Dahlquist, Éva Gyürüs et al. · 2009 · The Lancet · 1.9K citations
Epidemiology of Diabetes and Diabetes-Related Complications
Anjali D. Deshpande, Marcie Harris‐Hayes, Mario Schootman · 2008 · Physical Therapy · 1.7K citations
In 2005, it was estimated that more than 20 million people in the United States had diabetes. Approximately 30% of these people had undiagnosed cases. Increased risk for diabetes is primarily assoc...
Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012
Elizabeth J. Mayer‐Davis, Jean M. Lawrence, Dana Dabelea et al. · 2017 · New England Journal of Medicine · 1.4K citations
The incidences of both type 1 and type 2 diabetes among youths increased significantly in the 2002-2012 period, particularly among youths of minority racial and ethnic groups. (Funded by the Nation...
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
David B. Sacks, Mark A. Arnold, George L. Bakris et al. · 2011 · Clinical Chemistry · 1.4K citations
BACKGROUND Multiple laboratory tests are used to diagnose and manage patients with diabetes mellitus. The quality of the scientific evidence supporting the use of these tests varies substantially. ...
Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
Aidin Rawshani, Araz Rawshani, Stefan Franzén et al. · 2017 · New England Journal of Medicine · 1.3K citations
In Sweden from 1998 through 2014, mortality and the incidence of cardiovascular outcomes declined substantially among persons with diabetes, although fatal outcomes declined less among those with t...
Reading Guide
Foundational Papers
Start with Patterson et al. (2009; 1850 citations) for European registry methods and projections; DIAMOND Project Group (2006; 1072 citations) for global 1990-1999 baselines; Deshpande et al. (2008; 1723 citations) for U.S. epidemiology context.
Recent Advances
Mayer-Davis et al. (2017; 1450 citations) details 2002-2012 U.S. youth trends in minorities; Rawshani et al. (2017; 1292 citations) links incidence to cardiovascular outcomes.
Core Methods
Prospective multicentre registration (Patterson et al., 2009), worldwide incidence monitoring (Karvonen et al., 2000), and cohort trend analysis standardize rates per 100,000 under age 15.
How PapersFlow Helps You Research Epidemiology of Type 1 Diabetes Incidence Trends
Discover & Search
Research Agent uses searchPapers and citationGraph on 'type 1 diabetes incidence trends' to map DIAMOND (DIAMOND Project Group, 2006) connections to Patterson et al. (2009), revealing 1850-cited European trends. exaSearch uncovers global registries; findSimilarPapers extends to Mayer-Davis et al. (2017) U.S. youth data.
Analyze & Verify
Analysis Agent applies readPaperContent to extract incidence rates from Patterson et al. (2009), then runPythonAnalysis with pandas to plot 1989-2003 trends vs. projections. verifyResponse (CoVe) checks claims against Mayer-Davis et al. (2017); GRADE grading scores registry evidence quality for youth surges.
Synthesize & Write
Synthesis Agent detects gaps in post-2012 projections via contradiction flagging between DIAMOND (2006) and Mayer-Davis (2017). Writing Agent uses latexEditText, latexSyncCitations for Patterson et al. (2009), and latexCompile trend reports; exportMermaid diagrams birth cohort effects.
Use Cases
"Plot incidence trends from DIAMOND and EURODIAB registries 1990-2012"
Research Agent → searchPapers('DIAMOND type 1 diabetes') → Analysis Agent → readPaperContent(DIAMOND 2006) + runPythonAnalysis(pandas plot rates per 100k) → matplotlib graph of global rises.
"Draft LaTeX review of youth T1D incidence in minorities"
Synthesis Agent → gap detection(Mayer-Davis 2017) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(Patterson 2009, Mayer-Davis 2017) → latexCompile → PDF with cited trends.
"Find code for modeling T1D projections from registries"
Research Agent → searchPapers('T1D incidence modeling') → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis(test projection scripts on Patterson 2009 data).
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on 'type 1 diabetes incidence,' chaining citationGraph(DIAMOND 2006 → Patterson 2009) to structured reports on youth trends. DeepScan applies 7-step CoVe verification to Mayer-Davis (2017) minority data with GRADE scoring. Theorizer generates hypotheses on accelerator effects from registry contradictions.
Frequently Asked Questions
What defines Epidemiology of Type 1 Diabetes Incidence Trends?
It examines global patterns and rising pediatric rates using registries like DIAMOND (1990-1999) and EURODIAB (1989-2003), tracking per 100,000 incidence in children under 15 (Patterson et al., 2009).
What are key methods in this subtopic?
Multicenter prospective registration (Patterson et al., 2009) and worldwide cohort analysis (DIAMOND Project Group, 2006; Karvonen et al., 2000) standardize incidence rates across populations.
What are the most cited papers?
Patterson et al. (2009; 1850 citations) on European trends 1989-2003; Mayer-Davis et al. (2017; 1450 citations) on U.S. youth 2002-2012; DIAMOND Project Group (2006; 1072 citations) on global 1990-1999.
What open problems exist?
Post-2020 projections under climate effects, distinguishing cohort vs. period drivers, and harmonizing minority data across registries remain unresolved (Mayer-Davis et al., 2017; Patterson et al., 2009).
Research Diabetes and associated disorders with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Epidemiology of Type 1 Diabetes Incidence Trends with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers
Part of the Diabetes and associated disorders Research Guide